Investing
Stock
Business
Politics

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025

April 28, 2025

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post

Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement

next post

S&P 500 Rises from Bearish to Neutral, But Will It Last?

You may also like

FY25 Results Announcement

August 29, 2025

Appendix 4E

August 29, 2025

Charbone Hydrogene annonce les resultats financiers T2 2025

August 29, 2025

FY25 Preliminary Results Summary and Company Update

August 29, 2025

Charbone Hydrogen Announces Q2 2025 Financial Results

August 29, 2025

1911 Gold Commences PEA on True North Project...

August 28, 2025

Bold Ventures Receives Exploration Permits for the Burchell...

August 28, 2025

Heritage Mining Provides Exploration and Melba Project Update

August 28, 2025

Cartier Launches Ambitious 100,000-m Drill Program on Cadillac

August 28, 2025

NevGold Announces Entry Into Standstill With GoldMining

August 28, 2025

Leave a Comment Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

S&P 500 Breaking Out Again: What This Means for Your Portfolio

August 29, 2025
FY25 Results Announcement

August 29, 2025
Appendix 4E

August 29, 2025
FY25 Preliminary Results Summary and Company Update

August 29, 2025
Charbone Hydrogene annonce les resultats financiers T2 2025

August 29, 2025

About us
Contacts
Privacy Policy
Terms and Conditions
Email Whitelisting

Disclaimer: globalinvestmentpulse.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 globalinvestmentpulse.com | All Rights Reserved

Investing
Stock
Business
Politics